feed,title,long_url,short_url
Investors,"BridgeBio, Up 80% This Year, Just Unveiled Promising News For Its Pfizer Rival",https://www.investors.com/news/technology/bridgebio-attruby-acoramidis-cardiovascular-outcomes/,
